Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure

Oliver J Müller1,2, Markus B Heckmann1,2, Lin Ding1,2

  • 1Internal Medicine III, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.

Cardiovascular Research
|November 13, 2018
PubMed
Abstract

Insights

Heart failure involves significant metabolic changes in the heart and body. Targeting carnitine transport via OCTN2 shows promise for treating heart failure.

Area of Science:

  • Cardiovascular Biology
  • Metabolomics
  • Molecular Cardiology

Background:

  • Heart failure is marked by structural and metabolic cardiac remodeling.
  • Understanding metabolic shifts during heart failure progression is crucial for therapeutic development.

Purpose of the Study:

  • To investigate complex metabolic alterations during the transition from pathological hypertrophy to heart failure.
  • To identify novel biomarkers and therapeutic targets from systemic metabolic profiling.

Main Methods:

  • Mice underwent transverse aortic constriction (TAC) or sham surgery.
  • Metabolomic and transcriptional profiling of plasma, liver, skeletal muscle, and heart tissues were performed at 2, 4, and 6 weeks post-surgery.
  • Cardiac overexpression of Organic Cation/Carnitine Transporter 2 (OCTN2) was investigated as a therapeutic strategy.

Main Results:

  • Progressive alterations in cardiac metabolic pathways and gene expression indicated impaired mitochondrial function and a metabolic switch.
  • Significant metabolic changes, including depletion of essential fatty acids, were observed in the liver and skeletal muscle.
  • Circulating metabolites, particularly fatty acids, correlated with cardiac defects and heart function decline.
  • Decreased carnitine shuttling preceded mitochondrial dysfunction, highlighting OCTN2's role.
  • Cardiac OCTN2 overexpression improved ejection fraction and reduced fibrosis in TAC mice.

Conclusions:

  • Systemic metabolic profiling reveals widespread alterations in heart failure.
  • Metabolic and transcriptional data identify novel biomarkers and potential therapeutic targets for heart failure.
  • Targeting carnitine transport through OCTN2 offers a promising therapeutic avenue for heart failure.

Related Concept Videos

What is Metabolism?00:52

What is Metabolism?

Overview
131.8K
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.8K
Altered States of Awareness01:06

Altered States of Awareness

Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.1K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.2K